Prostate cancer detection and tumor characteristics in men with multiple biopsy sessions

Prostate Cancer and Prostatic Diseases

Volumn 7, Issue 3, 2004, Pages 238-242

  Lujan, M ^a   Paez, A ^b   Santonja, C ^a   Pascual, T ^a   Fernandez, I ^a   Berenguer, A ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

Author keywords

Mass screening; Prostate biopsy; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RISK FACTOR; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; BIOPSY; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS;

EID: 16644365600     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500730     Document Type: Article

References (14)

1. De Koning HJ et al. Large-scale randomized prostate cancer screening trials: Program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002; 97: 237-244.
2. Chang JJ, Shinohara K, Bhargava V, Presti JC. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 1998; 160: 2111-2114.
3. Presti JC, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial. J Urol 2000; 163: 163-167.
4. Bauer JJ et al. Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer. Urology 1999; 53: 961-967.
5. Zlotta AR, Raviv G, Schulman CC. Clinical prognostic criteria for later diagnosis of prostate carcinoma in patients with initial isolated prostatic intraepithelial neoplasia. Eur Urol 1996; 30: 249-255.
6. Borboroglu PG, Sur RL, Roberts JL, Amling CL. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol 2001; 166: 866-870.
7. Djavan B, Remzi M, Marberger M. When to biopsy and when to stop biopsying. Urol Clin N Am 2003; 30: 253-262.
8. Djavan B et al. Optimal predictors of prostate cancer on repeat biopsy: a prospective study of 1051 men. J Urol 2000; 163: 1144-1149.
9. Remzi M et al. An artificial neural network to predict the outcome of repeat prostate biopsies. Urology 2003; 62: 456-460.
10. Lopez-Corona E et al. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol 2003; 170: 1184-1188.
11. Mian BM et al. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 2002; 60: 836-840.
12. Djavan B et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop? J Urol 2001; 166: 1679-1683.
13. Ciatto S, Vis AN, Finne P. How to improve the specificity and sensitivity of biopsy technique in screening. BJU Int 2003; 92 (Suppl 2): 79-83.
14. Vis AN et al. The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: An evaluation from a randomized, population-based study of screening for prostate cancer. Cancer 2001; 92: 524-534.